Table 3.
Parameter estimates of the nonlinear mixed effect model for change in creatinine clearance (CrCL).
Description | Parameter | Unit | Estimates (RSE%) |
---|---|---|---|
Structural model estimates as reported in a previous meta-analysis (13) | |||
Baseline CrCL | CrCL0 | mL/min | 97.83 (3.91)* |
Maximum CrCL | CrCLMAX | — | 83.83 (12.48)* |
Time of half-maximum CrCL | CrCL50 | weeks | 13.3 (37.59)* |
| |||
Between subject variability (CV%) | |||
Baseline CrCL | ω CrCL0 | CV% | 31.4 (16) |
Maximum CrCL | ω CrCLMAX | CV% | 35.1 (17) |
Time of half-maximum CrCL | ω CrCL50 | CV% | 111.8 (121) |
| |||
Residual unexplained variability variance | |||
Proportional error | σ CrCL | 0.0291 (43) |
CrCL: creatinine clearance; RSE: relative standard error. *These values were fixed during estimation of the mixed effect model; that is, only random effects were estimated.